If Channel Inhibition - Ivabradine for the Treatment of Heart Failure
The novel first-in-class If channel antagonist, Ivabradine, is effective in improving clinical outcomes and functional capacity, in patients with HF, as well as demonstrating useful anti-anginal and protective anti-ischaemic effects. It can help improve heart rate control and can be usefully co-admi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Barcaray International
2019-01-01
|
Series: | International Cardiovascular Forum Journal |
Subjects: | |
Online Access: | https://icfjournal.org/index.php/icfj/article/view/599/pdf |